Breast cancer types
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest that breast cancer can be classified into various histological and molecular subtypes, with special types accounting for up to 25% of invasive cases, each having distinct clinical presentations, molecular characteristics, and prognoses.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Understanding Breast Cancer Types: Histological and Molecular Perspectives
Histological Types of Breast Cancer
Common and Special Histological Types
Breast cancer is a heterogeneous disease with multiple histological types, each with unique biological and clinical characteristics. The most common type is invasive ductal carcinoma not otherwise specified (IDC NOS), which accounts for the majority of cases. However, up to 25% of breast cancers are classified as histological special types, including invasive lobular carcinoma (ILC), mucinous, tubular, medullary, and others .
Clinical Characteristics of Histological Types
Different histological types of breast cancer exhibit distinct clinical behaviors. For instance, lobular and ductal/lobular carcinomas are more likely to present at advanced stages and with larger, node-positive tumors compared to ductal carcinomas. Conversely, mucinous, tubular, and papillary carcinomas tend to present at earlier stages and are associated with less aggressive phenotypes. Inflammatory carcinomas, on the other hand, are linked to more aggressive tumor characteristics.
Molecular Taxonomy of Breast Cancer
Molecular Subtypes
Breast cancer can also be classified based on molecular characteristics derived from gene expression profiles. The primary molecular subtypes include Luminal A, Luminal B, HER2-enriched, and basal-like. These subtypes provide insights into the tumor's behavior and response to treatment, influencing patient management strategies.
Genotypic-Phenotypic Correlations
Recent studies have shown that specific genetic alterations are associated with certain histological types. For example, secretory carcinomas often harbor the ETV6-NTRK3 fusion gene, while adenoid cystic carcinomas display the MYB-NFIB translocation. These genetic markers help in understanding the molecular underpinnings of different histological types and their clinical implications .
Integration of Histological and Molecular Classifications
Refining Breast Cancer Classification
Efforts to refine breast cancer classification systems have revealed that some histological special types constitute distinct molecular entities. For example, micropapillary carcinoma is a discrete entity, while others like tubular and lobular carcinomas show similarities at the transcriptome level. This refined classification aids in more accurate prognostication and identification of optimal therapeutic strategies.
Prognostic Implications
The histological diversity of breast carcinomas has significant prognostic implications. For instance, tubular carcinoma is associated with an indolent clinical course, whereas metaplastic cancer generally has an unfavorable outcome. Understanding these distinctions is crucial for tailoring treatment approaches and improving patient outcomes .
Conclusion
Breast cancer encompasses a wide spectrum of histological and molecular types, each with unique clinical and biological characteristics. Integrating histological and molecular classifications enhances our understanding of the disease, leading to more precise prognostication and personalized treatment strategies. As research continues to unravel the complexities of breast cancer, these insights will be pivotal in improving patient care and outcomes.
Sources and full results
Most relevant research papers on this topic
